Rose C Perri's Net Worth
-$23.4 Thousand
Who is Rose C Perri?
Rose C Perri does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include GENEREX BIOTECHNOLOGY CORP, and EASTGATE BIOTECH CORP.
SEC CIK
Rose C Perri's CIK is 0001125858
Past Insider Trading and Trends
2003 was Rose C Perri's most active year for acquiring shares with 10 total transactions. Rose C Perri's most active month to acquire stocks was the month of October. 2011 was Rose C Perri's most active year for disposing of shares, totalling 4 transactions. Rose C Perri's most active month to dispose stocks was the month of April. 2010 saw Rose C Perri paying a total of $18,900.00 for 454,000 shares, this is the most they've acquired in one year. In 2011 Rose C Perri cashed out on 636,752 shares for a total of $13,450.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GENEREX BIOTECHNOLOGY CORP No price found
COO, CFO& Treas.Rose C Perri owns 975,478 units of Common Stock. From 2003 to 2011 Rose C Perri acquired a total of 835,352 shares in GENEREX BIOTECHNOLOGY CORP at a cost of $36,886.75, Rose also disposed a total of 60,000 shares of GENEREX BIOTECHNOLOGY CORP equalling to $13,450.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.51% | -15.00K |
$0.23 | -$3,450.00 | 975.48K |
May 9
| |||
Form 4
| -1.98% | -20.00K |
$0.23 | -$4,500.00 | 990.48K |
May 6
| |||
Form 4
| -2.41% | -25.00K |
$0.22 | -$5,500.00 | 1.01M |
May 3
| |||
Form 4
| +125.73% | 576.75K |
—
| $576.75 | 1.04M |
Jan 3
| |||
Form 4
| +13.34% | 54K |
$0.35 | $18,900.00 | 458.73K |
Oct 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 20 - Mar 8
| |||
Form 4
| +2.53% | 10K |
$0.51 | $5,100.00 | 404.73K |
Nov 16
| |||
Form 4
| +3.95% | 15K |
$0.30 | $4,538.00 | 394.73K |
Oct 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
| +85.48% | 175K |
—
|
—
| 379.73K |
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
Form 4
| +0.24% | 500 |
$1.71 | $855.00 | 204.63K |
Jan 23
| |||
Form 4
| +0.05% | 100 |
$1.56 | $156.00 | 204.23K |
Dec 1
| |||
Form 4
| +0.25% | 500 |
$1.61 | $807.00 | 204.13K |
Nov 24
| |||
Form 4
| +0.25% | 500 |
$1.65 | $825.00 | 203.63K |
Nov 18
| |||
Form 4
| +0.49% | 1K |
$1.73 | $1,725.00 | 203.13K |
Nov 12 - Nov 17
| |||
Form 4
| +1.00% | 2K |
$1.70 | $3,404.00 | 202.13K |
Nov 4
| |||
| No matching records found | |||||||||
EASTGATE BIOTECH CORP No price found
President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||